Research
New Targeted Pill Shows Promise for Advanced Pancreatic Cancer
A new targeted treatment for advanced pancreatic cancer has shown encouraging early results in a major clinical trial. The experimental pill, darax...
POLAR Trial Offers New Hope for Some Patients With Metastatic Pancreatic Cancer
Early findings from the Phase 2 POLAR trial suggest that combining pembrolizumab and olaparib may benefit selected patients with metastatic pancrea...
PICCOS Clinical Trial Explores Innovative Treatment for Peritoneal Cancer
The PICCOS clinical trial is exploring an innovative chemotherapy approach called PIPAC for people with peritoneal cancer. Researchers hope this ta...
Switching Off KRAS: A Promising Breakthrough in Pancreatic Cancer Treatment
Results from the RASolute 302 phase 3 trial show the targeted drug Daraxonrasib improves survival in metastatic pancreatic cancer after prior treat...
Landmark New England Journal of Medicine (NEJM) Publication Advances Gastric Cancer Prevention
A new New England Journal of Medicine paper, led by International Agency for Research on Cancer, outlines practical guidance for Helicobacter pylor...
Breakthroughs, Reality Checks, and New Directions in HBP Cancer Care
The annual American Society of Clinical Oncology – Gastrointestinal (ASCO-GI) meeting highlighted a major shift in treating Hepato-Bilio-Panc...
Expanding the Biomarker Landscape on Gastric Cancer
New research presented at the 2026 ASCO GI meeting shows that understanding the biology of gastric and gastroesophageal cancers is driving more per...
UK eoCRC Consortium: Collaboration, Funding and Patient Voices in Edinburgh
On 11 November, the UK Early-Onset Colorectal Cancer Consortium (eoCRCC) held its third in-person meeting in Edinburgh, bringing together more than...
Personalised Progress in Gastric Cancer: Highlights from ESMO 2025
This year at ESMO, new research revealed improved methods to personalise treatment for gastric cancer. These approaches could help patients achieve...
Advancing Personalised Care: Key Colorectal Cancer Trials from ESMO 2025
New research at ESMO 2025 showcased progress in tailoring treatments for colorectal cancer. Highlights include using ctDNA to guide safer chemother...